Category: Portfolio

February 7, 2019

HYP3R is leading the transformation of location marketing to deliver experiences that are delightful and effective. HYP3R’s innovations in location marketing cloud help top marketers acquire and engage high-value customers in the real world through digital experiences that are surprisingly human. At the core of HYP3R is a unique dataset of hundreds of millions of the highest value consumers in the world that gives an edge to the leaders in travel and retail. HYP3R, one of Fast Company’s Most Innovative Companies, was founded in 2015 and is based in San Francisco. Learn more at https://hyp3r.com or follow @HYP3R on Twitter.

Read More

December 14, 2018

Mission Bio delivers targeted single-cell genomics solutions for high-impact applications with Tapestri, the Precision Genomics Platform. Tapestri is the industry’s first targeted single-cell DNA sequencing platform, enabling precise detection of heterogeneity in disease progression and treatment response. Application areas include blood cancers, solid tumors, and genome editing validation. The platform includes an instrument, consumables, and analysis software, which integrate seamlessly with existing NGS workflows. With Tapestri, researchers have a highly sensitive, targeted, and customizable solution to move precision medicine forward.

Read More

December 5, 2018

For Skates, 2018 was an especially momentous year. “I turned 30, we raised a Series D and I got engaged this year,” he said. “That’s going to be hard to top.”

Read More

November 26, 2018
  • Airbnb has hired Amazon VP Dave Stephenson as CFO ahead of its anticipated IPO in 2019.
  • Stephenson spent 17 years as Amazon, most recently as VP and CFO of Amazon’s Worldwide Consumer Organization, responsible for all global website sales. He also spent a couple years as President and CFO of Big Fish Games.
  • Stephenson is the second Amazon exec to join Airbnb this year, following Greg Greeley, who is president of Homes.
Read More

November 19, 2018

Raising a Series A is a huge accomplishment and closing it might feel like you’ve crossed the finish line but the pressure only goes up from here.

Read More

September 25, 2018

Mission Bio, Inc., the pioneer in high-throughput single-cell DNA analysis and precision genomics, today announced a first-of-its-kind study demonstrating its ability to perform single-cell DNA analysis at speed and scale orders of magnitude higher than prior methods. The study, published in Genome Research and co-authored by researchers at Mission Bio and MD Anderson Cancer Center, illustrates its Tapestri platform’s ability to identify the evolution of cellular mutations in Acute Myeloid Leukemia (AML) tumors. This study provides unprecedented insight into the cells that drive complex diseases like cancer and opens the door to the routine sequencing of tumors.

Read More

The venture capital industry is male dominated and some of its unfair practices have been brought to light with the rise of the #metoo movement in 2017. This got us to wonder: How do businesses approach diversity and inclusion? What does that mean for Mighty Capital? What does that mean for our portfolio? We have been committed to diversity and inclusion from day 1 and it’s an essential part of our culture that we summarize with Mark Twain’s famous quote: “Actions Speak Louder Than Words.”

Read More

© 2019 Mighty Capital All Rights Reserved